MAPS: pathologist-level cell type annotation from tissue images through machine learning.
Muhammad ShabanYunhao BaiHuaying QiuShulin MaoJason YeungYao-Yu YeoVignesh ShanmugamHan ChenBokai ZhuJason L WeiratherGarry P NolanMargaret A ShippScott J RodigSizun J JiangFaisal MahmoodPublished in: Nature communications (2024)
Highly multiplexed protein imaging is emerging as a potent technique for analyzing protein distribution within cells and tissues in their native context. However, existing cell annotation methods utilizing high-plex spatial proteomics data are resource intensive and necessitate iterative expert input, thereby constraining their scalability and practicality for extensive datasets. We introduce MAPS (Machine learning for Analysis of Proteomics in Spatial biology), a machine learning approach facilitating rapid and precise cell type identification with human-level accuracy from spatial proteomics data. Validated on multiple in-house and publicly available MIBI and CODEX datasets, MAPS outperforms current annotation techniques in terms of speed and accuracy, achieving pathologist-level precision even for typically challenging cell types, including tumor cells of immune origin. By democratizing rapidly deployable and scalable machine learning annotation, MAPS holds significant potential to expedite advances in tissue biology and disease comprehension.
Keyphrases
- machine learning
- rna seq
- single cell
- big data
- artificial intelligence
- mass spectrometry
- deep learning
- cell therapy
- label free
- electronic health record
- induced apoptosis
- endothelial cells
- high resolution
- gene expression
- protein protein
- magnetic resonance imaging
- stem cells
- amino acid
- convolutional neural network
- climate change
- small molecule
- binding protein
- bone marrow
- computed tomography
- optical coherence tomography
- risk assessment
- photodynamic therapy
- fluorescence imaging
- human health